News

The study compared GI-5005 plus standard of care (SOC) – pegylated-interferon plus ribavirin – versus SOC alone in patients with chronic genotype 1 hepatitis C infection. The GI-5005-02

In a 48-week boceprevir regimen, the sustained virologic response (SVR) rate was 74% at 12 weeks after the end of treatment (SVR 12) in patients who received four

In the Phase I study in healthy volunteers, ANA598 was administered as capsules at single oral doses of 400mg, 800mg, 1400mg, 2000mg and 3000mg. In addition, a separate

The Phase I studies are open-label, dose-escalating clinical trials in patients with incurable breast, bladder, pancreatic, or colorectal cancer, all tumors that can express hCG Beta. The studies

The TalentManager platform provides configurable pay-for-performance capabilities that can be mapped to a customer’s business requirements and internal processes. A flexible set of in-depth compensation and performance management

The agreement also includes the transfer of marketing-authorization for Concor, an anti-hypertensive medication, and Glucophage, a diabetes agent. It is the second agreement that Daiichi Sankyo and Merck

Mr Kohlbecher, who will be based in Germany, fills this newly created position to oversee all of Alphatec Spine’s European operations. Mr Kohlbecher will be responsible for directing

Mobile Diagnostic Centers, a mobile imaging services provider, hired Dr McNamara as director of marketing and operations in June 2008 with the original intention of having him replace

The grants are part of Delivering Hope, an umbrella program for Bristol-Myers Squibb’s efforts in the areas of hepatitis awareness, prevention and care. A total of five grants